The mission of the Oxford Cancer Immuno-Oncology Network (OCION) Funding Scheme is to pump-prime innovative Oxford-based immuno-oncology research and build capacity in cancer immunology.
Previous fund recipients are highlighted below:
Kim Midwood, The Kennedy Institute of Rheumatology
How does macrophage marker F4/80 control T cell tolerance during tumour progression? Finding new ways of taming inflammation to improve treatment options for people with cancer
Vaccination for cancer prevention in Lynch Syndrome
Alistair Easton, Department of Oncology
Phenotyping Intra-epithelial Lymphocytes in Pre-Invasive Lesions